| Financial Year |
September 30 2021 |
| Monetary Funds |
3,930,025.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
86,159,700.20 |
| Advances to Suppliers |
96,285,754.20 |
| Other Receivables |
712,663,571.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,538,282.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,244,905.76 |
| Total Current Assets |
917,822,239.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,645,527.03 |
| Investment Properties |
-- |
| Fixed Assetes |
108,132,275.48 |
| Under-construction Projects |
33,158,878.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,224,453.88 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,328,028.81 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
23,683,199.57 |
| Sub-Total of Non-Current Assets |
238,410,568.26 |
| Total Assets |
1,156,232,807.82 |
| Short-Term Loans |
176,119,735.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
203,737,611.93 |
| Accounts Received In Advance |
344,834.93 |
| Employee Compensation Payable |
28,194,914.52 |
| Taxes Payable |
90,308,777.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,997,109.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
541,702,983.91 |
| Long-term Loans |
59,069,420.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
102,423,945.51 |
| Deferred Income Tax Liabilities |
8,784,047.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
170,277,413.00 |
| Total Liabilities |
711,980,396.91 |
| Paid-In Capital(Or Share Stock) |
469,970,000.00 |
| Capital Surplus |
2,597,595,806.10 |
| Surplus Reserve |
4,138,068.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,694,447,886.87 |
| Minority Stockholder's Interest |
60,396,546.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
383,855,863.99 |
| Owner's Equity（Stockholder's Equity） |
444,252,410.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,156,232,807.82 |
